Overall rank by patents
#2,517
of 49,997 tracked assignees
USPTO PatentsView assignee record - 155 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, ONO ranks #2,517 of 49,997 tracked US assignees by granted-patent volume, with 155 patents across 19 technology areas.
USPTO PatentsView assignee plate
Corpus R2517 · Foreign Corporation #2,517 · 155 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Genomatica, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
CertainTeed Ceilings · near
43 score
The Ames Companies · near
43 score
Conagra Foods RDM · near
43 score
ONO Pharmaceutical · this assignee
43 score
Sony · near
43 score
3D Lighting… · lowest
7 score
What this shows ONO's Innovation Score is 43.4/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
ONO Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 19 CPC subclasses with 96.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (21 grants) versus a trough of 7 in 2022. By volume, ONO sits between Genomatica, Inc. and Atlassian, Inc..
From 2019–2021 to 2022–2024, ONO Pharmaceutical Co., Ltd. moved from 49 to 24 grants (0.49x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,718. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Genomatica, Inc.
155 patents
Idemia Identity & Security France
155 patents
Newport Fab, LLC
155 patents
Oce-technologies B.V.
155 patents
Safran Seats USA LLC
155 patents
Tenneco GmbH
155 patents
Wilson Sporting Goods Co.
155 patents
ONO Pharmaceutical Co., Ltd.
155 patents
Atlassian, Inc.
154 patents
What this shows ONO holds 155 patents at rank #2,517, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,517 in granted patent volume.
Other assignees with the most granted patents in ONO's primary technology class.
Two PlainPatent-derived peer sets for ONO, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (43 here).
Nearest assignees by average claims per patent (12.1 here).
ONO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 28% higher than 72% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 11.6% |
| 2016 | 18 | 11.6% |
| 2017 | 18 | 11.6% |
| 2018 | 21 | 13.5% |
| 2019 | 21 | 13.5% |
| 2020 | 17 | 11.0% |
| 2021 | 11 | 7.1% |
| 2022 | 7 | 4.5% |
| 2023 | 7 | 4.5% |
| 2024 | 10 | 6.5% |
| 2025partial year | 7 | 4.5% |
Top 15 of 19 technology areas
Overall rank by patents
#2,517
of 49,997 tracked assignees
43.4 out of 100
What to do with this data
ONO Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.